Edition:
United States

Sarepta Therapeutics Inc (AB3A.F)

AB3A.F on Frankfurt Stock Exchange

35.04EUR
17 Jan 2017
Change (% chg)

€-0.15 (-0.44%)
Prev Close
€35.19
Open
€35.04
Day's High
€35.04
Day's Low
€35.04
Volume
--
Avg. Vol
640
52-wk High
€55.50
52-wk Low
€8.03

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.68 December 17 Jan 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 6 6 6 6
(2) OUTPERFORM 7 6 6 5
(3) HOLD 5 4 4 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.94 1.88 1.88 1.79

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 12 15.83 32.93 6.60 25.80
Quarter Ending Jun-17 12 31.60 65.80 11.90 52.90
Year Ending Dec-17 17 150.23 487.80 66.00 187.32
Earnings (per share)
Quarter Ending Mar-17 13 -0.68 2.47 -1.29 -0.87
Quarter Ending Jun-17 13 -0.70 0.01 -1.11 -0.39
Year Ending Dec-17 15 -2.22 3.62 -4.39 -1.57

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 1.06 0.00 1.06 100.00
Quarter Ending Jun-16 0.09 0.00 0.09 100.00
Quarter Ending Mar-16 0.18 0.00 0.18 100.00
Quarter Ending Dec-15 0.00 1.25 1.25 65,847.37
Quarter Ending Sep-15 0.00 0.00 0.00 100.00
Earnings (per share)
Quarter Ending Sep-16 -1.32 -1.18 0.14 -10.29
Quarter Ending Jun-16 -1.19 -1.35 0.16 -13.13
Quarter Ending Mar-16 -1.28 -1.31 0.03 -2.04
Quarter Ending Dec-15 -1.18 -1.44 0.26 -22.03
Quarter Ending Sep-15 -1.18 -1.25 0.07 -5.93

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 15.83 17.75 21.51 21.51 25.80
Quarter Ending Jun-17 31.60 30.56 34.77 34.77 52.90
Year Ending Dec-17 150.23 158.29 210.16 215.13 187.32
Earnings (per share)
Quarter Ending Mar-17 -0.68 -0.65 -0.88 -0.89 -0.87
Quarter Ending Jun-17 -0.70 -0.73 -0.62 -0.63 -0.39
Year Ending Dec-17 -2.22 -2.14 -1.48 -1.46 -1.57

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 1 4 0 4
Quarter Ending Jun-17 2 2 0 4
Year Ending Dec-17 3 4 0 11
Earnings
Quarter Ending Mar-17 2 3 1 3
Quarter Ending Jun-17 2 2 1 3
Year Ending Dec-17 2 3 1 6